In Canada, all of these weight loss medications can be used in adult patients with an initial body mass index (BMI) of: 30 Kg/m2 or greater, or 27 Kg/m2 or greater in the presence of at least one weight-related comorbidity (ie, high blood pressure, type 2 diabetes, high cholesterol, fatty liver, sleep apnea, etc) To find out if any of these agents are covered on your benefits plan, use each of the drug identification numbers (DIN) listed below each medication name to check with your benefits plan or pharmacy
When fat cells shrink, they release hormones differently, and this can lead to lighter, heavier, shorter, or longer periods
Semaglutide GLP-1 works by slowing down gastric emptying and increasing satiety, which can help reduce appetite and aid in weight loss
Rosen explained that allodynia is a type of nerve pain that occurs when things that should not cause discomfort do
Based on a study of HIV-negative people, the Food and Drug Administration last year approved Wegovy for the treatment of MASH in people with moderate to advanced fibrosis